Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000595628> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2000595628 abstract "Chemotherapy induced nausea and vomiting (CINV) is among the most feared side effects of chemotherapy for cancer patients and is associated with significant deterioration in quality of life. The major risk factors for CINV are emetogenic potential of chemotherapeutic agents, repeated chemotherapy cycles and patient risk factors (younger age, female gender, history of motion sickness, alcohol consumption). The use of first generation 5-hydroxytryptanine (5-HT3) receptor antagonists (ondansetron, tropisetron, dolasetron and granisetron) in combination with dexamethason has significantly improved the control of acute CINV. Additional improvement in the control of acute and delayed CINV for highly and moderately emetogenic chemotherapy has been demonstrated recently with two newer antiemetic agents, a second generation 5-HT3 receptor antagonist palonosetron and neurokinin-1 (NK-1) receptor antagonist aprepitant. However, the role of palonosetron with respect to old 5-HT3 antagonists remains to be verified when both are combined with dexamethason in the first 24 hours and recommended therapies for delayed emesis. Aprepitant is a current standard of care for the prevention of acute and delayed CINV in patients receiving highly emetogenic chemotherapy. The value of this agent has been demonstrated also in breast cancer patients receiving anthracycline-based chemotherapy. Despite recent progress, a significant number of patients still develop CINV. To further improve control of acute and delayed CINV many questions remain to be addressed in ongoing and future properly designed randomized clinical trials. These include use of new antiemetic combinations as are palonosetron and aprepitant with current and other agents (olanzepin, gabapentin, midazolam, gherlin); new NK1 antagonists; single day vs. multiple days dosing of antiemetics and in different clinical settings (multiple days chemotherapy, bone marrow transplantation)." @default.
- W2000595628 created "2016-06-24" @default.
- W2000595628 creator A5059994428 @default.
- W2000595628 date "2007-09-24" @default.
- W2000595628 modified "2023-10-18" @default.
- W2000595628 title "Antiemetics – current standards and open questions" @default.
- W2000595628 doi "https://doi.org/10.1055/s-2007-990387" @default.
- W2000595628 hasPublicationYear "2007" @default.
- W2000595628 type Work @default.
- W2000595628 sameAs 2000595628 @default.
- W2000595628 citedByCount "0" @default.
- W2000595628 crossrefType "journal-article" @default.
- W2000595628 hasAuthorship W2000595628A5059994428 @default.
- W2000595628 hasConcept C126322002 @default.
- W2000595628 hasConcept C143998085 @default.
- W2000595628 hasConcept C170493617 @default.
- W2000595628 hasConcept C2776712918 @default.
- W2000595628 hasConcept C2776885963 @default.
- W2000595628 hasConcept C2777170512 @default.
- W2000595628 hasConcept C2777452722 @default.
- W2000595628 hasConcept C2778144076 @default.
- W2000595628 hasConcept C2779924295 @default.
- W2000595628 hasConcept C2780574406 @default.
- W2000595628 hasConcept C2780580376 @default.
- W2000595628 hasConcept C2780884295 @default.
- W2000595628 hasConcept C42219234 @default.
- W2000595628 hasConcept C71924100 @default.
- W2000595628 hasConceptScore W2000595628C126322002 @default.
- W2000595628 hasConceptScore W2000595628C143998085 @default.
- W2000595628 hasConceptScore W2000595628C170493617 @default.
- W2000595628 hasConceptScore W2000595628C2776712918 @default.
- W2000595628 hasConceptScore W2000595628C2776885963 @default.
- W2000595628 hasConceptScore W2000595628C2777170512 @default.
- W2000595628 hasConceptScore W2000595628C2777452722 @default.
- W2000595628 hasConceptScore W2000595628C2778144076 @default.
- W2000595628 hasConceptScore W2000595628C2779924295 @default.
- W2000595628 hasConceptScore W2000595628C2780574406 @default.
- W2000595628 hasConceptScore W2000595628C2780580376 @default.
- W2000595628 hasConceptScore W2000595628C2780884295 @default.
- W2000595628 hasConceptScore W2000595628C42219234 @default.
- W2000595628 hasConceptScore W2000595628C71924100 @default.
- W2000595628 hasIssue "03" @default.
- W2000595628 hasLocation W20005956281 @default.
- W2000595628 hasOpenAccess W2000595628 @default.
- W2000595628 hasPrimaryLocation W20005956281 @default.
- W2000595628 hasRelatedWork W100286279 @default.
- W2000595628 hasRelatedWork W1980587497 @default.
- W2000595628 hasRelatedWork W2085651211 @default.
- W2000595628 hasRelatedWork W2099365808 @default.
- W2000595628 hasRelatedWork W2110464778 @default.
- W2000595628 hasRelatedWork W2150644462 @default.
- W2000595628 hasRelatedWork W2233598186 @default.
- W2000595628 hasRelatedWork W2323150078 @default.
- W2000595628 hasRelatedWork W2477337376 @default.
- W2000595628 hasRelatedWork W3096722963 @default.
- W2000595628 hasVolume "4" @default.
- W2000595628 isParatext "false" @default.
- W2000595628 isRetracted "false" @default.
- W2000595628 magId "2000595628" @default.
- W2000595628 workType "article" @default.